<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01160627</url>
  </required_header>
  <id_info>
    <org_study_id>CIN in STEMI</org_study_id>
    <nct_id>NCT01160627</nct_id>
  </id_info>
  <brief_title>Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction</brief_title>
  <official_title>Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJECTIVE: To evaluate the efficacy of prevention of contrast induced nephropathy in patients
      with ST segment elevation myocardial infarction treated with primary percutaneous coronary
      intervention.

      DESIGN: Prospective study. SETTING: Three-center study Acute kidney injury was defined as a
      rise in creatinine &gt;25% from baseline Serum creatinine will be measured at baseline and each
      day for the following 3 days and at 30 days.

      Patients will be randomised to:

        1. Standard treatment

        2. Standard treatment + acetylcystein for 2 days

        3. Standard treatment + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours

        4. Standard treatment + acetylcystein for 2 days + Sodium bicarbonate 500 ml / followed by
           100 ml/h for 5 hours
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI</measure>
    <time_frame>from baseline to day 3</time_frame>
    <description>Rise in creatinine &gt;25% from baseline to day 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI</measure>
    <time_frame>from baseline to day 30</time_frame>
    <description>Rise in creatinine &gt;25% from baseline to day 30</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">720</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Acetylcystein and Sodium Bicarbonat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Bicarbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetylcystein for 2 days</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment + acetylcystein for 2 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hydration</intervention_name>
    <description>Saline hydration</description>
    <arm_group_label>Standard treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylcysteine</intervention_name>
    <description>Acetylcystein tablets for 2 days</description>
    <arm_group_label>Acetylcystein for 2 days</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium bicarbonate</intervention_name>
    <description>Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours</description>
    <arm_group_label>Sodium Bicarbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combined Acetylcystein and Sodium Bicarbonate</intervention_name>
    <description>Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours combined with acetylcystein tablets for 2 days</description>
    <arm_group_label>Combined Acetylcystein and Sodium Bicarbonat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  STEMI patients treated with primary PCI

        Exclusion Criteria:

          -  Cardiogenic shock
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Thayssen, MD DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2010</study_first_submitted>
  <study_first_submitted_qc>July 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2010</study_first_posted>
  <last_update_submitted>March 21, 2013</last_update_submitted>
  <last_update_submitted_qc>March 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Lisette Okkels Jensen</investigator_full_name>
    <investigator_title>MD DMSci PhD</investigator_title>
  </responsible_party>
  <keyword>CIN STEMI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

